Bristol to buy Inhibitex for hepatitis C treatment | Reuters
Links shared publicly online about this topic.
- 0total visits
Bristol to buy Inhibitex for hepatitis C treatment | Reuters
(Reuters) - Bristol-Myers Squibb Co has agreed to acquire Inhibitex Inc for about $2.5 billion to gain access to its promising hepatitis C treatment, the companies said on Saturday.At $26 per share, the
View full resource at reuters.com
Tags: Liver Condition, Hepatitis, Hepatitis C, Healthy Living, Bristol-Myers Squibb, News
Most Recently Shared on January 8, 2012 at 4:42 am By:
Bristol to buy Inhibitex for hepatitis C treatment: (Reuters) - Bristol-Myers Squibb Co has agreed... http://t.co/0ivxHpZR #health #news
Bristol to buy Inhibitex for hepatitis C treatment
health.yahoo.net — “(Reuters) - Bristol-Myers Squibb Co has agreed to acquire Inhibitex Inc for about $2.5 billion to gain access to its promising hepatitis C treatment, the companies said on Saturday. At $26 per share, the deal is a huge 163 percent premium to Inhibitex's closing price of $9.87 on Friday.” View full resource at health.yahoo.net
Most Recently Shared on January 8, 2012 at 6:40 am By:
Bristol to buy Inhibitex for hepatitis C treatment http://t.co/ntPmBUw7
Advertisement
